TRICLIP
Device
Abbott Laboratories
Total Payments
$3.2M
Transactions
483
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3.2M | 483 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.2M | 483 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal | Abbott Laboratories | $2.5M | 0 |
| Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | Abbott Laboratories | $540,035 | 0 |
| Hemodymanic Monitoring to Prevent Adverse Events Following Cardiogenic Shock (HALO-Shock) Trial | Abbott Laboratories | $90,639 | 0 |
| Preclinical Assessment of Electrogram Frequency Redistribution to Monitor Radiofrequency Catheter Ablation Lesion Formation | Abbott Laboratories | $62,483 | 1 |
| Use of a personalized shared decision-making session to optimize utilization of pulmonary artery pressure monitoring technology with evidence-based benefits in decreasing hospitalizations for patients with heart failure (HF). | Abbott Laboratories | $8,550 | 0 |
| Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid Regurgitation (TRILUMINATE) | Abbott Laboratories | $6,395 | 0 |
| CAS TRILUMINATE Pivotal Trial | Abbott Laboratories | $900.00 | 0 |
| Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair SystemPivotal | Abbott Laboratories | $810.00 | 0 |
Top Doctors Receiving Payments for TRICLIP
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Bay Shore, NY | $3.1M | 482 |
| , MD | Internal Medicine | Boston, MA | $62,483 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $3.2M
Product Information
- Type Device
- Total Payments $3.2M
- Total Doctors 1
- Transactions 483
About TRICLIP
TRICLIP is a device associated with $3.2M in payments to 1 healthcare providers, recorded across 483 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2024 to 2024. In 2024, $3.2M was paid across 483 transactions to 1 doctors.
The most common payment nature for TRICLIP is "Unspecified" ($3.2M, 100.0% of total).
TRICLIP is associated with 8 research studies, including "Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal" ($2.5M).